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The ability of HIV to match levels of viral mRNA to the activation state of the host cell may play a role in its ability to persist
as well as to replicate. This linkage depends on the function of the viral transcriptional regulatory protein, Tat, which
increases the efficiency of RNA elongation (transcriptional processivity) in response to cellular activation. To quantify levels
of Tat function in vivo, a quantitative competitive RT-PCR assay was developed that reflects levels of TAR leader fragments
(nonprocessive transcripts) and viral mRNA (processive transcripts), indicating low or high levels of Tat function, respectively.
The abundance of these RNA species was measured in peripheral blood mononuclear cells (PBMC) of 22 HIV-1-positive
individuals (CD41 T cell counts 63–934/mm3) and in established cell line models of HIV constitutive replication (H9IIIB) and
reversible latency (U1 and ACH-2). In PBMC, the level of total viral transcripts ranged over four orders of magnitude; however,
nonprocessive transcription predominated: 70% of PBMC samples had a ratio of processive to total transcripts of ,0.3 and
none of the samples had 100% processivity. The cell line studies revealed that, even in activated H9IIIB cells, nonprocessive
transcription dominates and that latently infected cells can have different transcriptional responses to activation. This is the
first study that enumerates degrees of transcriptional processivity in the circulating mononuclear cell compartment and the
results suggest that limitation of Tat function may be a common phenotype throughout the course of the disease. © 1999
Academic Press
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The development of highly active antiretroviral thera-
ies (HAART) for treatment of HIV infection has focused
ttention on the need to understand the relationship
etween productive and latent infection. Productive in-
ection has been characterized as a dynamic equilibrium
etween HIV and the immune system in which rapid viral
eplication is countered by equally active, but incom-
lete, viral clearance (Ho et al., 1995; Perelson et al.,
996; Wei et al., 1995). This equilibrium is reflected in the
evel of plasma viremia that remains stable throughout
symptomatic infection and is currently the best predic-
or of system-wide viral replicative activity and the rate of
isease progression (Mellors et al., 1996, 1997). In-
reased rates of viral production are determined by a
ariety of regulatory interactions involving both viral and
ost factors. These include (a) level of cellular activation
nd induction of host transcriptional regulators such as
FkB and NFATc (Kinoshita et al., 1998; Nabel and Bal-
imore, 1987); (b) interaction of the viral transactivator,
at, with the host factors cyclin T1 and CDK9 at the viral
ransactivation response element (TAR) (Cujec et al.,
1 Present address: Roche Molecular Systems, Alameda, CA.
2 Present address: Ernest Gallo Clinic and Research Center, Depart-
ent of Neurology, UCSF, San Francisco General Hospital, San Fran-
isco, CA 94110.
3 To whom correspondence and reprint requests should be ad-
ressed. Fax: (415) 338-7747. E-mail: jromeo@sfsu.edu.
397997; Wei et al., 1998); and (c) regulation of viral RNA
ransport by the viral transactivator, Rev (Pomerantz et
l., 1990; Saksela et al., 1994).
The mechanism by which HIV might establish and
aintain cellular latency is less well understood. How-
ver, it may ultimately be the ability of the virus to main-
ain cellular latency that allows it to elude both the
mmune system and antiretroviral therapy. Many studies
rovide evidence for down-regulation or attenuation of
iral gene expression. In situ hybridization studies of
ymphoid tissue, where rates of viral replication are high-
st (Pantaleo et al., 1993), show that .99% of HIV-1
nfected cells produce little or no detectable viral RNA
Embretson et al., 1993). The properties of these cryptic
roviruses are controversial and mechanisms of latency
nvolving both preintegration and postintegration events
ave been identified (Zack et al., 1990; Chun et al., 1995;
inzi and Silliciano, 1998). HIV provirus also has the
otential to be reactivated; it has been shown that qui-
scent T cells contain integrated provirus in a state of
eversible latency (Chun et al., 1995). Viral replication
lso can be induced by mitogenic stimulation of periph-
ral blood mononuclear cells (PBMC) from individuals
ho have had subdetectable levels of plasma viremia for
p to 2 years (Chun et al., 1997a,b; Finzi et al., 1997; Wong
t al., 1997). These studies demonstrate the potential of
IV to establish a reservoir of provirus within long-lived
nfected lymphocytes that can disseminate infectious
irus following activation.Multiple mechanisms may contribute to viral latency.
0042-6822/99 $30.00
Copyright © 1999 by Academic Press
All rights of reproduction in any form reserved.
S
v
(
a
T
r
1
e
a
a
T
t
p
s
s
p
s
d
v
c
(
b
s
h
s
a
e
o
s
(
t
a
t
d
t
r
T
i
u
c
S
w
a
c
s
R
d
c
i
e
p
e
t
l
s
q
c
l
t
a
a
i
w
d
t
t
t
l
L
a
i
c
398 ADAMS ET AL.ince viral replication depends on T cell activation, both
irus and host regulatory factors are undoubtedly crucial
Grossman et al., 1998). Our previous semiquantitative
nalysis of transcriptional patterns in HIV1 PBMC and
at-reconstituted cell line models of latency suggested a
ole for Tat in maintaining HIV latency (Adams et al.,
994). Tat stimulates efficient viral transcription and is an
ssential regulator of all viral gene expression. In the
bsence of Tat, cellular transcription factors assemble
nd initiate viral RNA synthesis but cannot complete it.
his attenuated RNA synthesis, termed nonprocessive
ranscription, leads to the accumulation of short, non-
olyadenylated RNAs containing the transactivation-re-
ponse-element (TAR) sequence in a 59-nucleotide
tem-loop (Kao et al., 1987). In the presence of Tat, stable
rocessive transcription proceeds efficiently to synthe-
ize mRNA. Tat activity can therefore be monitored by
etermining levels of promoter proximal (nonprocessive)
s promoter distal (processive) transcription, which indi-
ate low and high levels of Tat function, respectively
Adams et al., 1994).
The role of Tat in regulating HIV gene expression has
een extensively studied both in recombinant in vitro
ystems and in tissue culture models of HIV infection. We
ave developed a sensitive and quantitative RT-PCR as-
ay (Fig. 1), with which the relationship between Tat
ctivity (degree of processivity) and levels of viral gene
xpression (mRNA synthesis) was enumerated in PBMC
f 22 HIV-1 infected individuals. Cell line models of con-
titutively productive infection and reversible latency
H9IIIB, U1, and ACH-2 cells) were evaluated for levels of
ranscriptional processivity at rest and following cellular
ctivation. The results provide the first direct demonstra-
ion of a correlation between degree of Tat activity and
egree of viral gene expression in PBMC and indicate
hat limitation of Tat-associated transcription may be a
FIG. 1. Detection of processive and nonprocessive transcripts by RT-
TR showing the positions of the primer combinations specific for the a
nd processive transcripts) and processive transcripts (primers 113). A
nto the recombinant plasmid pLTR* used to generate the external sta
ontrols for quantitative competitive RT-PCR analysis of PBMC.esting viral state in vivo. cRESULTS
ranscriptional processivity in H9IIIB cells increases
n response to mitogenic stimulation
The T-lymphocytic H9IIIB cell line has been widely
sed for the propagation and study of active HIV repli-
ation in cell culture (Kim et al., 1989; Mann et al., 1989).
emiquantitative analysis of transcriptional processivity
as performed in this cell line to determine levels of Tat
ctivity found under permissive conditions of viral repli-
ation. Relative amounts of processive and total tran-
cripts were estimated by dilutional end-point analysis of
NA purified from these cells after growth under stan-
ard conditions or mitogen stimulation. A standard
urve, generated with pLTR* control RNA, was included
n each experiment to control for interassay variability in
fficiency of reverse transcription, amplification, and
robe hybridization. The system was sensitive to the
quivalent of 100 copies of LTR* RNA (Fig. 2A). To aid in
he interpretation of band intensities, signals were ana-
yzed by digital image analysis of the autoradiograms. It
hould be noted that this assay was considered “semi-
uantitative” for two reasons. First, there is no internal
ontrol for tube to tube variability. Second, because both
iquid hybridization and PCR have a potential for a pla-
eau effect at high concentration, the linear range of the
ssay is at the low-end dilutions where stochastic vari-
tion (Poisson effect) is a primary cause of variability.
Viral transcription was predominantly nonprocessive
n the unstimulated H9IIIB cells (Fig. 2B). Total transcripts
ere estimated to be 10- to 100-fold more abundant (two
ilutions greater) than processive transcripts (Fig. 2B,
able; “Total” lane 3 vs “Processive” lane 1), suggesting
hat Tat activity may be a limiting factor for virus produc-
ion even under conditions of high viral replication. Fol-
owing mitogenic stimulation, total transcription in-
hematic representation of the transcription initiation region in the HIV
ation of total HIV transcripts (primers 112 amplify both nonprocessive
icated is the site at which 31 bp of exogenous sequence was inserted
curves for semiquantitative RT-PCR analysis of cell lines and internalPCR. Sc
mplific
lso ind
ndardreased approximately 10-fold (one dilution) (Fig. 2B;
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399HIV-1 TRANSCRIPTIONAL PROCESSIVITY IN VIVOTotal”, lane 3 vs lane 8) and processive transcription
ncreased 100-fold (two dilutions) (Fig. 2B; “Processive”,
ane 2 vs lane 8). These results suggest that the accu-
ulation of processive transcripts was mediated by a
ynergistic interaction involving a similar (approximately
0-fold) increase in the rate of transcriptional initiation
nd transcriptional processivity, consistent with a Tat
ffect.
1 and ACH-2 cell lines both show nonprocessive
ranscription but demonstrate different transcriptional
esponses to mitogenic stimulation
The ACH-2 and U1 cell lines, derived from HIV-1 in-
ected lymphocytic (CEM) and promonocytic (U937) pa-
ental cell lines, respectively, have been extensively
tudied as models of viral latency and activation (Adams
t al., 1994; Butera et al., 1994; Pomerantz et al., 1990). In
he unstimulated state, both express low levels of HIV-1
hat dramatically increase following cellular activation.
asal RNA synthesis in both cell lines consists predom-
nantly of multiply spliced transcripts coding for regula-
ory proteins (Pomerantz et al., 1990). Following activa-
ion, virions are produced in the previously quiescent
ells and singly spliced and unspliced mRNAs coding for
tructural proteins are readily detectable. Using semi-
uantitative RT-PCR, we examined each cell line before
nd after mitogenic stimulation for the degree of non-
rocessive and processive transcription.
FIG. 2. Processivity of transcription in the productively infected H9IIIB
ere amplified with primers 112 (Total) or primers 113 (Processive
mounts of labeled PCR products were combined, labeled by liquid
roducts were generated from the equivalent of 104, 103, and 102 copie
ach run to control for interassay differences in RT-PCR efficiency. (B)
timulation. Tenfold serial dilutions of cDNA were amplified using the
emiquantitative analysis was performed. Signal intensities were quan
f the analysis; the values do not represent input RNA copy number aBoth unstimulated cell lines showed similar RNA pat- derns with nonprocessive transcription predominating
Fig. 3, lanes 1–3 and 7–9). Following cellular activation,
oth cell lines increased RNA synthasis. In the U1 cells,
timulation was accompanied by a greater than 10-fold
ncrease in the relative abundance of processive tran-
cripts compared to what was observed prestimulation
Fig. 3, “Processive” lanes 4–6 vs lanes 1–3), consistent
ith elevated levels of Tat activity. In contrast, although
he ACH-2 cells showed an approximately 10-fold in-
e. (A) Tenfold dilutions of cDNA derived from the LTR* RNA standard
arate reactions, as described under Materials and Methods. Equal
zation, and fractionated by polyacrylamide gel electrophoresis. PCR
A (lanes 1–3). Signal intensity for each primer pair was monitored in
ell RNA was purified before (lanes 1–4) and after (lanes 5–8) mitogen
specific for total and processive transcripts as described above and
y digital image analysis and are listed to highlight the relative nature
not increase in a linear fashion.
FIG. 3. U1 and ACH-2 cells respond differently to mitogen stimula-
ion. RNA was purified from U1 cells (left) and ACH-2 cells (right) before
lanes 1–3 and 7–9) and after (lanes 4–6 and 10–12) mitogen stimula-
ion. Semiquantitative analysis was performed on 10-fold dilutions ascell lin
) in sep
hybridi
s of RN
H9IIIB c
primers
tified bescribed above.
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400 ADAMS ET AL.rease in total RNA production, the extent of processivity
as only modestly affected (Fig. 3, lane 7 vs lane 11).
ere, nonprocessive and processive transcription in-
reased almost equally, consistent with stimulation of
ranscription in the absence of a Tat effect.
ranscriptional processivity and viral mRNA synthesis
n HIV-infected PBMC
To study the impact of Tat activity on levels of viral
RNA expression in PBMC, we analyzed fresh samples
rom 22 HIV-1 infected individuals by quantitative–com-
etitive RT-PCR. Processive transcripts were quantified
nd a processivity ratio (processive transcripts/total tran-
cripts) was computed as described under Materials and
ethods. Among different individuals, levels of proces-
ive transcripts in PBMC ranged over four orders of
agnitude (Fig. 4A). Processivity ratios ranged from zero
two individuals) to 0.71 (mean 6 SD of 0.21 6 0.21),
orresponding to totally nonproductive and highly effi-
ient transcription, respectively. There were no subjects
n which 100% processivity was detected. Figure 4A dem-
nstrates that increasing processivity ratios were asso-
iated with increasing levels of processive transcript (P
0.001), consistent with in vitro findings.
Figure 4B diagrams the relationship between nonpro-
essive and processive transcripts. At low levels of
RNA there was a 10- to 100-fold excess of nonproces-
ive transcripts. However, the slope of the regression
FIG. 4. Transcriptional processivity in PBMC of HIV-infected individua
ivided by total viral transcripts (corrected for the terminal redundancy o
eflect increasing Tat-associated processive transcription. (A) Levels
ompetitive RT-PCR and used to compute the processivity ratio for eac
ranscripts (#/100 ng). Two samples had processivity ratios of zero; the
g) and processive transcripts (#/100 ng) increase together (R2 5 0.83)
ranscripts; at low levels, nonprocessive transcripts are 10- to 100-fold
dashed line) at higher levels. (C) Correlation between CD41 T cell coine intersects the line of unity at high levels of mRNA, endicating that the rate of increase in processive tran-
cripts was faster than that of nonprocessive transcripts.
The scatter of the data presented in Figs. 4A and 4B is
ot unexpected considering that the levels of RNA were
ormalized to a standard amount of total PBMC RNA
nd, therefore, were not corrected for variations in the
roviral burdens likely to exist among the 22 individuals
onitored. Since the proviral burden commonly differs by
wo or more orders of magnitude among different indi-
iduals (Bagasra et al., 1993), the yield of viral RNA from
given number of PBMC would be expected to vary
ccordingly. Nevertheless, a correlation between proces-
ivity and viral RNA yield is apparent.
CD41 T cell count did not correlate with processivity
atio (Fig. 4C), nor did it correlate with absolute proces-
ive, nonprocessive, or total transcript levels (data not
hown). These findings are similar to those of Mellors et
l., (1996, 1997), who have demonstrated that plasma
iral loads do not correlate with CD41 cell count.
DISCUSSION
Similar to several cellular proto-oncogenes, HIV regu-
ates its gene expression by controlling transcriptional
rocessivity (Toth et al., 1995; Xu et al., 1995). Using
uantitative RT-PCR, we demonstrate that, as predicted
y in vitro systems, the degree of transcriptional proces-
ivity correlates positively with the relative abundance of
rocessive transcripts, consistent with a positive Tat
“processivity ratio” is defined as the number of processive transcripts
n mRNA, as described under Materials and Methods). Increasing ratios
total and processive transcripts were determined by quantitative-
le. The processivity ratio is plotted against the number of processive
not included in the log-transformed values. (B) Nonprocessive (#/100
ver, processive transcripts increase at a faster rate than nonprocessive
r than processive transcripts, with their ratio converging toward unity
d processivity ratio (R2 nonsignificant).ls. The
f TAR o
of HIV
h samp
se were
. Howe
higheffect (Fig. 4A). Our results also reveal that the dominant
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401HIV-1 TRANSCRIPTIONAL PROCESSIVITY IN VIVOranscriptional pattern in HIV-infected PBMC has a Tat-
imited phenotype. Enumeration of the range of Tat func-
ion in PBMC highlighted the predominance of low pro-
essivity ratios throughout the course of the disease.
mong the 22 HIV1 individuals, processivity ratios
anged from 0 to 0.71 with two PBMC samples (9%)
emonstrating entirely nonprocessive patterns of tran-
cription (no detectable Tat function) and 70% of the
amples demonstrating a processivity ratio less than 0.3
Fig. 4A). In contrast, the processivity ratio was greater
han 0.6 in only 2 samples and there were no samples
ith 100% processivity. These results suggest that viral
roduction may be greatly suppressed in circulating
ononuclear cells due to limitation of Tat-associated
ranscription.
It should be noted the processivity ratio represents the
verage value for the population of cells analyzed. For
FIG. 4xample, a processivity ratio of 0.1 could be obtained in 1homogeneous population (with respect to processivity)
n which each cell has a processivity of 0.1 or, alterna-
ively, in a heterogeneous population in which 90% of
ells demonstrate zero processivity and 10% of cells
emonstrate 100% processivity (assuming equal rates of
ranscription). While this assay is insensitive to transcrip-
ional processivity within individual infected cells, the
esults consistently suggest that nonprocessive tran-
cription is the dominant mode of transcription in vivo.
Regulation of processivity within PBMC may be medi-
ted by multiple mechanisms involving both viral and
ost regulatory factors. Our data are consistent with a
Tat threshold” mechanism in which fluctuations in the
ate of transcriptional initiation are either reinforced or
ounterbalanced by the activities of Tat and its cellular
artners. The requirement for the interaction of Tat, cyclin
1, and CDK9 (Cujec et al., 1997; Cullen, 1998; Wei et al.,
inued998) for the transition to processive transcription allows
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402 ADAMS ET AL.or the integration of multiple regulatory factors, each of
hich may respond differently to the metabolic state of
he cell. Different induction pathways for CDK9 and cy-
lin T1 have recently been demonstrated in peripheral
lood T cells and two promonocytic cell lines (the pro-
yelomonocytic cell line HL-60 and the myelomonocytic
ell line U937) (Herrmann et al., 1998). The flexibility of
his regulatory scheme may be further augmented by the
bility of the viral Nef protein to affect cellular activation
athways (Bandres and Ratner, 1994; Baur et al., 1994;
aksela, 1997; Saksela et al., 1995). It is therefore plau-
ible that the normal viral life cycle includes a regulatory
athway in which wild-type Tat activity decreases with
ellular deactivation so that a latent state may be estab-
ished. It is also possible that genetic variation may
nfluence levels of Tat activity, since the transition to
rocessive transcription directly exposes the infected
ell to immune surveillance. Extensive variation in tat
ene sequences are commonly seen among provirus in
BMC and the virus they establish in culture (Meyerhans
t al., 1989; Sabino et al., 1993, 1994).
The promonocytic U1 and lymphocytic ACH-2 cell line
odels of latency provide well-characterized examples
f distinct viral mutations producing Tat-restricted phe-
otypes. As shown in Fig. 3, both unstimulated cell lines
howed a nonprocessive RNA pattern; however, follow-
ng mitogen stimulation, the transcriptional response dif-
ered markedly between cell lines. In U1, stimulation led
o an increase in both the rate and the processivity of
ranscription, consistent with a Tat effect. U1 cells con-
ain two integrated HIV proviruses, each with mutant tat:
ne blocked by the deletion of a translational initiation
odon with the other encoding a form of Tat containing a
istidine to leucine mutation at amino acid 13 (Emiliani et
l., 1998). This mutation causes a decrease in the trans-
ctivation potency of the mutant Tat protein; however, it
as been shown that higher levels of Tat can compen-
ate for the defect (Adams et al., 1994; Emiliani et al.,
998). The mitogenic stimulation of U1 cells may suffi-
iently increase the levels of endogenous Tat (and cel-
ular cofactors) to overcome the block to viral replication.
n contrast, ACH-2 cells contain a single provirus that
ncodes wild-type Tat activity; however, the proviral LTR
ontains a point mutation in the Tat-binding site, TAR
Emiliani et al., 1996). Mutation of the TAR stem-loop is
hought to lead to decreased responsiveness to endog-
nous or exogenous Tat. As this observation predicts,
hile total viral transcripts increased following mitogenic
timulation of transcriptional initiation (Fig. 3B), stimula-
ion of ACH-2 caused only approximately 2-fold increase
n processivity, in contrast to the 10- to 100-fold increase
n processivity seen in U1 cells following stimulation.
It was not possible to determine from the small num-
er of subject samples analyzed to determine whether
he level of processivity in PBMC correlated with disease
tage or drug therapy. It might be predicted that bursts of liral activity (increased processivity ratio) are countered
y immune selection toward increased “hidden” virus
decreased processivity ratio), reflecting an individual-
zed cycle that varies in rate and degree as the disease
rogresses. The predictive value of any given ratio will
equire longitudinal analysis of a larger number of indi-
iduals. It also remains to be determined whether viral
ranscription rates in PBMC correlate with system-wide
iral replicative activity, as reflected by plasma viral load.
ny relationship between the two would be expected to
e indirect, since PBMC are thought to contribute less
han 1% to levels of plasma viremia (Ho et al., 1995;
erelson et al., 1996; Wei et al., 1995). Further study is
ecessary to determine whether transcription patterns in
BMC will reflect system-wide viral replicative rate, HIV
ctivity in lymphoid tissue, or the severity of stem cell
nd lymph node destruction.
Following treatment with HAART, turnover of plasma
irus and virus in lymphoid tissue is rapid but turnover of
nfected PBMC occurs more slowly; a major subpopula-
ion of infected PBMC demonstrate a half-life indistin-
uishable from that of uninfected PBMC (Cavert et al.,
997; Ho et al., 1995; Wei et al., 1995). The evidence
resented here suggests that many of these cells con-
ain subspecies of virus that initiate transcription but do
ot complete it, perhaps because of variant Tat/TAR or
ow concentrations of Tat or regulatory cofactors. The
inding that nonprocessive transcription predominates in
irculating mononuclear cells adds strength to the sug-
estion that viral latency may be maintained by control of
ranscriptional processivity and provides clues to future
herapeutic strategies. It is clear that effective monitoring
nd treatment of HIV will require addressing the latent as
ell as the replicative potential of the virus.
MATERIALS AND METHODS
Patient samples and cell culture. Samples from 22
IV-1 infected individuals were kindly provided by Dr.
oel Palefsky, University of California, San Francisco.
amples were obtained from residual anti-coagulated
EDTA) whole blood, following CD41 and CD81 T cell
etermination. Subjects ranged in disease stage: 12
symptomatic, 3 AIDS-related condition, 4 AIDS, and 3
or whom clinical stage was not available. Anti-retroviral
herapy varied widely; 14 were taking one or more nu-
leic acid analogs, 2 were also on protease inhibitors.
either plasma nor plasma viral load analysis was avail-
ble on this cohort. PBMC were separated with Sepra-
ell-MN (Sepratech, Oklahoma City, OK) within 24 h of
ollection. U1, ACH-2, and H9IIIB cell lines were main-
ained in RPMI with 10% FBS. For stimulation of cell lines,
mg/ml PHA plus 50 ng/ml PMA was added to the
edium as previously described (Adams et al., 1994).
Isolation of RNA and cDNA synthesis. RNA was iso-ated from 2 3 106 cultured cells as previously described
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403HIV-1 TRANSCRIPTIONAL PROCESSIVITY IN VIVOAdams et al., 1994). RNA was purified from PBMC by
xtraction with organic solvents (TriReagent, Sigma). Fol-
owing treatment with DNase 1, reverse transcription of
NA (1 mg) was performed with random primers under
tandard conditions using Moloney murine leukemia vi-
us reverse transcriptase (Bethesda Research Laborato-
ies, Gaithersburg, MD).
Primers and probes. Primer pair design is diagrammed
n Fig. 1. Sequences of primers and probes were derived
rom the HIV-1BRU LTR (Meyers et al., 1993) as follows:
rimer 1, GGGTCTCTCTGGTTAGA (positions 454 to 470);
rimer 2, GGGTTCCCTAGTTAGCC (positions 512 to 496);
rimer 3, CTGCTAGAGATTTTCCACACTGAC (positions
35 to 612); TAR loop probe, GCCTGGGAGCTCTCTGG
positions 481 to 497).
Semiquantitative analysis by RT-PCR. Cell culture sam-
les were analyzed using a semiquantitative RT-PCR
echnique. Following reverse transcription, serial dilu-
ions of cDNA samples were separately amplified with
ach primer pair (Fig. 1). Samples negative for reverse-
ranscriptase were always run in parallel to control for
NA contamination. PCR was performed with AmpliTaq
sing commercially available kits (Perkin–Elmer-Cetus
orp., Norwalk, CT), according to the manufacturer’s
pecifications; hot start and carryover prevention proto-
ols (Perkin Elmer-Cetus Corp.) were also employed. The
hermal profile for amplification included 30 cycles of
0 s at 95°C, 20 s at 56°C, and 40 s at 72°C. Amplified
roducts were detected by liquid hybridization using the
2P-labeled TAR loop probe as previously described (Lee
t al., 1991) and electrophoresis on 10% nondenaturing
olyacrylamide gels. Autoradiogram band intensity was
uantified by digital image analysis (Nucleotech, Inc.).
uantitative analysis of the raw data was interpreted
ith the understanding that the assay could reveal only
ualitative differences.
An RNA standard was synthesized in vitro using T7
NA polymerase from the plasmid pLTR*. This plasmid
ontains 31 bp of heterologous DNA inserted between
he binding sites for primers 112 (Fig. 1). Tenfold serial
ilutions of LTR* cDNA were amplified with each primer
air. The signal intensity of amplicons generated by both
rimer combinations indicated similar efficiencies of RT-
CR for each primer combination (Fig. 2A). An LTR*
tandard curve was included with all cell culture exper-
ments to monitor interassay variation.
Quantitative analysis by competitive RT-PCR. RNA
pecimens from subject PBMC were analyzed by inter-
ally controlled quantitative competitive RT-PCR. Sample
NA (1.0 mg) was reverse transcribed together with dilu-
ions of competitor pLTR*RNA (105, 104, 103, 102, and 10
opies per RT reaction). The cDNA mixture (2 ml) was
mplified separately with each set of primers in a 20-ml
CR using an optimized cDNA Polymerase Mix (Clon-
ech Laboratories, Inc.). PCR products were resolved by
lectrophoresis on 3% agarose gels, stained with Tthidium bromide, and quantified by digital image anal-
sis (Nucleotech, Inc.). Target copy numbers were deter-
ined from input copy number of competitor as de-
cribed (Piatak et al., 1993). The internal control RNA for
hese experiments was generated from the plasmid
LTR* by in vitro synthesis with T7 RNA polymerase.
ontrol experiments were performed to verify that LTR*
ompetitor was amplified with virtually identical effi-
iency to target and that efficiency of reverse transcrip-
ion of nonprocessive transcripts was similar to that of
rocessive transcripts (data not shown).
Computation of processivity ratio. The processivity ra-
io is defined as the number of processive transcripts
ivided by total viral transcripts. Primers 113 are spe-
ific for processive transcripts only (see Fig. 1) and the
umber of targets quantified with these primers is a
irect measure of processive (mRNA) transcripts. Prim-
rs 112 amplify all viral transcripts, leading to the rela-
ionship
Total112 5 Processive112 1 Nonprocessive112, (1)
here Total112 is the total number of targets quantified
y primers 112, Processive112 is the number of targets
uantified by primers 112 from processive transcripts,
nd Nonprocessive112 is the number of targets quanti-
ied by primers 112 from nonprocessive transcripts.
However, because of the terminal reduncy of TAR on
RNA, quantification with primers 112 is complicated
y the fact that one mRNA will compete with two mole-
ules of competitor (which contains a single TAR region
nly). The relationship between the two targets quanti-
ied by primers 112 from each processive transcript
Processive112), and the specific number of proces-
ive transcripts (quantified by primers 113) may be de-
cribed as
Processive112 5 2*Processive113, (2)
here Processive113 is the number of targets quantified
y primers 113 from processive transcripts. Equation (1)
hen can be rearranged to yield
Total112 5 2*Processive113 1 Nonprocessive112. (3)
ecause the values for Total112 and Processive113 are
erived experimentally. Nonprocessive transcripts can
e quantified by
Nonprocessive112 5 Total112 2 ~2*Processive113!. (4)
herefore, the processivity ratio is calculated as the
umber of processive transcripts per total transcripts,
ith “true” total transcripts equal to processive tran-
cripts 1 nonprocessive transcripts.
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